ECRID, INC
CIK:0000811868|SEC Filings
Condensed Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Income Statement [Abstract] | ||||
| Revenues | ||||
| Operating expenses | ||||
| General and administrative | 19,646 | 2,608 | 61,335 | 89,771 |
| Total operating expenses | (19,646) | (2,608) | (61,335) | (89,771) |
| Loss from operations | (19,646) | (2,608) | (61,335) | (89,771) |
| Loss before income tax provision | (19,646) | (2,608) | (61,335) | (89,771) |
| Income tax provision | ||||
| Net loss | $ (19,646) | $ (2,608) | $ (61,335) | $ (89,771) |
| Loss per share - basic | $ (0.00) | $ (0.00) | $ (0.00) | $ (0.00) |
| Loss per share - diluted | $ (0.00) | $ (0.00) | $ (0.00) | $ (0.00) |
| Weighted average common shares outstanding - basic | 283,893,944 | 283,893,944 | 291,469,317 | 283,893,944 |
| Weighted average common shares outstanding - diluted | 283,893,944 | 283,893,944 | 291,469,317 | 283,893,944 |
Condensed Statements of Cash Flows (Unaudited) - USD ($) |
9 Months Ended | |
|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Cash Flows From Operating Activities: | ||
| Net loss | $ (61,335) | $ (89,771) |
| Stock based compensation for services | 21,996 | |
| Changes in operating assets and liabilities: | ||
| Due to/from officer | 34,456 | (78,725) |
| Accounts payable and accrued expenses | 231,800 | |
| Other | 1 | |
| Net Cash Provided by (Used in) Operating Activities | (4,882) | 63,304 |
| Cash flows from Investing Activities | ||
| Cash flows from Financing Activities | ||
| Net change in cash and cash equivalents | (4,882) | 63,304 |
| Cash and cash equivalents at beginning of reporting period | 10,019 | |
| Cash and cash equivalents at end of reporting period | 5,137 | 68,304 |
| Supplemental disclosures of cash flow information: | ||
| Interest paid | ||
| Income tax paid | ||
Condensed Balance Sheets (Unaudited) - USD ($) |
Dec. 31, 2022 |
Mar. 31, 2022 |
|---|---|---|
| Current Assets | ||
| Cash and cash equivalents | $ 5,137 | $ 10,019 |
| Total Assets | 5,137 | 10,019 |
| Current Liabilities | ||
| Accounts payable and accrued expenses | 20,000 | 20,000 |
| Payable to officer | 36,953 | 2,496 |
| Total Liabilities | 56,953 | 22,496 |
| Stockholders’ Deficit | ||
| Common stock par value $0.0001: 700,000,000 shares authorized; 291,489,503 as of December 31, 2022 and 291,389,503 as of March 31, 2022 shares issued and outstanding, respectively | 29,150 | 29,140 |
| Additional paid-in capital | 10,634,291 | 10,612,305 |
| Accumulated deficit | (10,715,257) | (10,653,922) |
| Total Stockholders’ Deficit | (51,816) | (12,477) |
| Total Liabilities and Stockholders’ Deficit | $ 5,137 | $ 10,019 |